Increasing Tysabri dosing interval may cut PML risk
Increasing Tysabri dosing interval may cut PML risk
Freedom from relapse was maintained in multiple sclerosis patients on Tysabri who received the infusion drug less frequently than the recommended 4-week interval, with lower risk of progressive multifocal leukoencephalopathy (PML), preliminary results from an ongoing analysis have indicated...... Read More - http://www.ms-uk.org/tysabri
MS-UK - http://www.ms-uk.org/
Re: Increasing Tysabri dosing interval may cut PML risk
Prior to any flag waving, please note that this is not a randomized double blind controlled trial...
Weinshenker commented that selection of patients for extended dosing, which was not random, might have involved "biases against committing more aggressive MS patients on the extended interval program, which might reduce the ability of the investigators to detect reduction in efficacy."
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2573 Views
-
Last post by NHE
-
- 0 Replies
- 548 Views
-
Last post by NHE
-
- 6 Replies
- 7775 Views
-
Last post by ElliotB
-
- 0 Replies
- 1423 Views
-
Last post by NHE
-
- 0 Replies
- 3808 Views
-
Last post by NHE
-
- 0 Replies
- 584 Views
-
Last post by NHE
-
- 0 Replies
- 3497 Views
-
Last post by NHE
-
- 1 Replies
- 1161 Views
-
Last post by NHE
-
- 11 Replies
- 3535 Views
-
Last post by NHE